iGenix in the News:

First CLIA approved assay.
iGenix Debuts Illumina BeadXpress-based Warfarin PGx Test, Plans More Assays
--July 26, 2011
The assay, which genotypes two genes in order to guide dosing of the anticoagulant warfarin, is "one of several" in iGenix's pipeline, according to a company official.

iGenix achieves Illumina CSPro.
In Brief This Week: iGenix, Illumina;
-- November 12, 2010
NEW YORK (GenomeWeb News) – Seattle-based iGenix has been named an Illumina certified service provider for the BeadXpress platform. iGenix said that it specializes in biomarker evaluation and helps clients develop new diagnostic assays for the BeadXpress platform.